Keeping tabs on our Phase 1 Clinical Trial - IHL675A
Confirmation of Enrolments for Phase 1 Trial - IHL-675A ( Wonder Drug!)
Appears 1st patient was enrolled on 31/08/22.
Appears the last enrolment is anticipated to be 31/10/22
Last data collection on 4/11/2022
According to
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382780&isReview=true
It is going to be an exciting time for news flow for IHL-675A also,
in the coming weeks/months, as per @tossydog
I think we all wondered how the Brains Trust would manage a study for concussion / TBI in humans!
looks like @tossydog has answered that for us; with it being studied in EMERGENCY DEPARTMENTS.
Good luck all holders, have a great weekend.